Chris Damas Lexaria Bioscience Corp LXX-CN WATCH Jul 06, 2017

Edible Markets. He researched the patent and it was created by two ladies in Florida. It was for a tea. He wants to know how it will work. CBD oil mixed with fats won’t get past the liver to the blood stream. He thinks there is a lot of upside in the edibles market but he wants to see few competitors otherwise they will not make much money.

Chris Damas

Unknown

Unlock Rating

$0.380

Stock price when the opinion was issued

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

WATCH

They developed a technology that works for edibles and extracted cannabis products. They signed deals with smaller cannabis companies. He is watching and waiting for validation of their technology from a larger company. They also allow companies to deliver nicotine in non-smoking ways.

COMMENT

He's watching it and will visit them in July. Everyone is looking into THC beverages with a shelf life. They've signed deals in the U.S.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Chris Damas Lexaria Bioscience Corp LXX-CN WATCH Jul 06, 2017

You might be interested:

Lexaria Bioscience Corp(LXX-CN)

Lexaria Bioscience Corp(LXX-CN)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Bruce Murray

The Panic-Proof Portfolio (Stockchase Research)

The Weekly Buzzing Stocks by Billy Kawasaki

Chris Blumas

Stockchase Insights